News Features Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions? Todd Neale October 22, 2025
News Features Reimbursement Issues Seem to Be Holding Renal Denervation Back Todd Neale December 19, 2024
News Opinion Off Script Evoque and Patisiran: A Tale of Two Regulatory Journeys Sanjay Kaul, MD March 29, 2024
News Daily News As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions L.A. McKeown August 18, 2023
News Conference News EuroPCR 2023 Renal Denervation: Exploring Its Potential Beyond Hypertension Todd Neale May 18, 2023
News Conference News AHA 2022 SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint Todd Neale November 09, 2022
News Conference News TCT 2022 SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss Michael O'Riordan September 19, 2022
News Conference News ACC 2021 Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO Michael O'Riordan May 16, 2021
News Conference News TCT 2020 Treating Accessory Arteries May Be Important in Renal Denervation Todd Neale October 18, 2020
News Daily News Renal Denervation Lowers BP Across High-risk Groups: Global SYMPLICITY Registry Todd Neale June 09, 2020
News Conference News TCT 2018 TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More Shelley Wood September 17, 2018